Third Rock Ventures’s Global Blood Therapeutics GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
SM
Third Rock Ventures's GBT Position: Q3 2015 in Review
Third Rock Ventures opened a new position in Global Blood Therapeutics (GBT) in Q3 2015: 14,760,900 shares worth $622M. The stake represents 58.1% of the portfolio and ranks #1 among its holdings.
59 funds tracked by Wall St. Rank hold GBT as of Q3 2015.
- Third Rock Ventures held 14,760,900 shares of Global Blood Therapeutics worth $622M as of Q3 2015.
- Global Blood Therapeutics was a new Third Rock Ventures position in Q3 2015.
- Global Blood Therapeutics made up 58.1% of Third Rock Ventures's portfolio in Q3 2015, its #1 holding.
- 59 funds tracked by Wall St. Rank held Global Blood Therapeutics as of Q3 2015.
Based on Third Rock Ventures's 13F filing for Q3 2015, filed 3 Nov 2015.